Lung Adenocarcinoma Invasiveness Risk in Pure Ground-Glass Opacity Lung Nodules Smaller than 2 cm

Abstract

Background We aimed to identify clinicopathologic characteristics and risk of invasiveness of lung adenocarcinoma in surgically resected pure ground-glass opacity lung nodules (GGNs) smaller than 2 cm.

Methods Among 755 operations for lung cancer or tumors suspicious for lung cancer performed from 2012 to 2016, we retrospectively analyzed 44 surgically resected pure GGNs smaller than 2 cm in diameter on computed tomography (CT).

Results The study group was composed of 36 patients including 11 men and 25 women with a median age of 59.5 years (range, 34–77). Median follow-up duration of pure GGNs was 6 months (range, 0–63). Median maximum diameter of pure GGNs was 8.5 mm (range, 4–19). Pure GGNs were resected by wedge resection, segmentectomy, or lobectomy in 27 (61.4%), 10 (22.7%), and 7 (15.9%) cases, respectively. Pathologic diagnosis was atypical adenomatous hyperplasia, adenocarcinoma in situ, minimally invasive adenocarcinoma (MIA), or invasive adenocarcinoma (IA) in 1 (2.3%), 18 (40.9%), 15 (34.1%), and 10 (22.7%) cases, respectively. The optimal cutoff value for CT-maximal diameter to predict MIA or IA was 9.1 mm. In multivariate analyses, maximal CT-maximal diameter of GGNs ≥10 mm (odds ratio, 24.050; 95% confidence interval, 2.6–221.908; p = 0.005) emerged as significant independent predictor for either MIA or IA. Estimated risks of MIA or IA were 37.2, 59.3, 78.2, and 89.8% at maximal GGN diameters of 5, 10, 15, and 20 mm, respectively.

Conclusion Pure GGNs were highly associated with lung adenocarcinoma in surgically resected cases, while estimated risk of GGNs invasiveness gradually increased as maximal diameter increased.

Keywords

lung cancer - adenocarcinoma - ground-glass opacity lung nodules - histopathology

^* Both authors contributed equally to this work.

• References

• 1 Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008; 246 (03) 697-722
• 2 Matsuguma H, Mori K, Nakahara R. , et al. Characteristics of subsolid pulmonary nodules showing growth during follow-up with CT scanning. Chest 2013; 143 (02) 436-443
• 3 Chang B, Hwang JH, Choi YH. , et al. Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan. Chest 2013; 143 (01) 172-178
• 4 Silva M, Sverzellati N, Manna C. , et al. Long-term surveillance of ground-glass nodules: evidence from the MILD trial. J Thorac Oncol 2012; 7 (10) 1541-1546
• 5 Aberle DR, Berg CD, Black WC. , et al; National Lung Screening Trial Research Team. The National Lung Screening Trial: overview and study design. Radiology 2011; 258 (01) 243-253
• 6 Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. ; International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006; 355 (17) 1763-1771
• 7 Naidich DP, Bankier AA, MacMahon H. , et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology 2013; 266 (01) 304-317
• 8 Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart. J Thorac Oncol 2015; 10 (09) 1240-1242
• 9 Lee SM, Park CM, Goo JM, Lee HJ, Wi JY, Kang CH. Invasive pulmonary adenocarcinomas versus preinvasive lesions appearing as ground-glass nodules: differentiation by using CT features. Radiology 2013; 268 (01) 265-273
• 10 Kakinuma R, Noguchi M, Ashizawa K. , et al. Natural history of pulmonary subsolid nodules: a prospective multicenter study. J Thorac Oncol 2016; 11 (07) 1012-1028
• 11 Scholten ET, de Jong PA, de Hoop B. , et al. Towards a close computed tomography monitoring approach for screen detected subsolid pulmonary nodules?. Eur Respir J 2015; 45 (03) 765-773
• 12 Lim HJ, Ahn S, Lee KS. , et al. Persistent pure ground-glass opacity lung nodules ≥ 10 mm in diameter at CT scan: histopathologic comparisons and prognostic implications. Chest 2013; 144 (04) 1291-1299
• 13 Yamaguchi M, Furuya A, Edagawa M. , et al. How should we manage small focal pure ground-glass opacity nodules on high-resolution computed tomography? A single institute experience. Surg Oncol 2015; 24 (03) 258-263
• 14 Kim H, Park CM, Woo S. , et al. Pure and part-solid pulmonary ground-glass nodules: measurement variability of volume and mass in nodules with a solid portion less than or equal to 5 mm. Radiology 2013; 269 (02) 585-593
• 15 McWilliams A, Tammemagi MC, Mayo JR. , et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 2013; 369 (10) 910-919
• 16 Hwang IP, Park CM, Park SJ. , et al. Persistent pure ground-glass nodules larger than 5 mm: differentiation of invasive pulmonary adenocarcinomas from preinvasive lesions or minimally invasive adenocarcinomas using texture analysis. Invest Radiol 2015; 50 (11) 798-804
• 17 Cho JH, Choi YS, Kim J, Kim HK, Zo JI, Shim YM. Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules. Ann Thorac Surg 2015; 99 (01) 218-222
• 18 Detterbeck FC, Homer RJ. Approach to the ground-glass nodule. Clin Chest Med 2011; 32 (04) 799-810
• 19 Suzuki K, Kusumoto M, Watanabe S, Tsuchiya R, Asamura H. Radiologic classification of small adenocarcinoma of the lung: radiologic-pathologic correlation and its prognostic impact. Ann Thorac Surg 2006; 81 (02) 413-419
• 20 Seki N, Sawada S, Nakata M. , et al. Lung cancer with localized ground-glass attenuation represents early-stage adenocarcinoma in nonsmokers. J Thorac Oncol 2008; 3 (05) 483-490
• 21 Sim HJ, Choi SH, Chae EJ. , et al. Surgical management of pulmonary adenocarcinoma presenting as a pure ground-glass nodule. Eur J Cardiothorac Surg 2014; 46 (04) 632-636 , discussion 636
• 22 Asamura H. Role of limited sublobar resection for early-stage lung cancer: steady progress. J Clin Oncol 2014; 32 (23) 2403-2404
• 23 Cho S, Yang H, Kim K, Jheon S. Pathology and prognosis of persistent stable pure ground-glass opacity nodules after surgical resection. Ann Thorac Surg 2013; 96 (04) 1190-1195
• 24 Eguchi T, Kondo R, Kawakami S. , et al. Computed tomography attenuation predicts the growth of pure ground-glass nodules. Lung Cancer 2014; 84 (03) 242-247
• 25 Ichinose J, Kohno T, Fujimori S, Harano T, Suzuki S, Fujii T. Invasiveness and malignant potential of pulmonary lesions presenting as pure ground-glass opacities. Ann Thorac Cardiovasc Surg 2014; 20 (05) 347-352
• 26 Liang J, Xu XQ, Xu H. , et al. Using the CT features to differentiate invasive pulmonary adenocarcinoma from pre-invasive lesion appearing as pure or mixed ground-glass nodules. Br J Radiol 2015; 88 (1053): 20140811
• 27 Fournel L, Etienne H, Mansuet Lupo A. , et al. Correlation between radiological and pathological features of operated ground glass nodules. Eur J Cardiothorac Surg 2016
• 28 Moon Y, Sung SW, Lee KY, Sim SB, Park JK. Pure ground-glass opacity on chest computed tomography: predictive factors for invasive adenocarcinoma. J Thorac Dis 2016; 8 (07) 1561-1570
• 29 Zha J, Xie D, Xie H. , et al. Recognition of “aggressive” behavior in “indolent” ground glass opacity and mixed density lesions. J Thorac Dis 2016; 8 (07) 1460-1468
• 30 Kitami A, Sano F, Hayashi S. , et al. Correlation between histological invasiveness and the computed tomography value in pure ground-glass nodules. Surg Today 2016; 46 (05) 593-598